Abstract
Background Silicosis is one of the most common forms of pneumoconiosis worldwide. In Rwanda - there is paucity of data on the silicosis burden and occupational risk among underground miners.
Methods We conducted a cross-sectional study among all miners from 8 cassiterite (tin ore) mining sites in Kayonza district, Eastern Rwanda. Questionnaire data and chest radiography were collected at Rwinkwavu District Hospital. Two radiologists reviewed all the chest radiography using ILO criteria, with a third radiologist reviewing films with ILO rating discrepancies and serving as an arbiter. Logistic regression was performed to investigate risk factors associated with radiographic silicosis.
Findings In total, 1,021 mine workers were included in the primary outcome (risk) analysis. The median age was 32 years (IQR 26-40), and 948 participants (93%) were male. Of all participants, 94 (9%) were diagnosed with silicosis. Increased odds of silicosis were associated with working in a blasting station (aOR 3·30; 95% CI 1·68-6·45), excavation station (aOR 2·77; 95% CI 1·09-7·04), drilling station (aOR 2·51; 95% CI 1· 34-4· 70), exposure to tobacco (aOR 1·92; 95% CI 1· 14-3· 24), and increased time of working in mining (aOR 1·05; 95% CI 1·01-1·09).
Interpretation Almost 1 in 10 Cassiterite miners in an occupational cohort of active and retired miners in the Eastern Province of Rwanda were found to have Silicosis. Tobacco use, certain mining tasks and duration of mining employment were significantly associated with increased risk of having a silicosis diagnosis. Our results indicate that screening and preliminary occupational risk analysis in a rural mining cohort is technically feasible.
Funding All funding was provided by internal grants through the Non-Communicable Diseases program through Partners in Health/Inshuti Mu Buzima
What is Already Known on this Topic Silicosis is recognized as a “Disease of Concern” for Low- and Middle-Income countries (LMICs) and is resurgent in parts of the United States and Australia. While the pathophysiology and preventative interventions necessary to address the development of silicosis, Little is known about the risk of mining related lung disease in Eastern Africa and no studies have been done in cassiterite miners in areas under conflict minerals regulation in our review of the literature.
What this Study Adds The objectives of this study were threefold. First, to determine the radiographic prevalence of silicosis in a mining cohort in Eastern Rwanda. Second, to identify risk factors associated with the development of silicosis present in cassiterite mining in semi-formal mines. Third, to develop a methodology for identifying and tracking mining-related disease in a rural community reliant on the mining economy.
How this study might affect research, practice or policy Our paper, in combination with available evidence, supports that silicosis continues to be a significant cause of morbidity and mortality in underground mining populations. It elucidates mechanisms within mining practice in Eastern Africa likely contributing to a high rate of advanced and accelerated silicosis in a region typically difficult to access for clinical surveillance programs. It also adds evidence of occupational risk associated with a pervasive and common mineral, cassiterite. Finally, it calls into question epidemiologic data on the true rates of silicosis in mining communities in Eastern Africa.
Competing Interest Statement
Paul Sonenthal has received grant support from Unitaid, CHEST, the Wyss Foundation, the World Bank, the WHO and CHAI for expanding the provision of oxygen in low- and middle-income countries and expanding critical care resources in developing countries. He also has received consulting fees from UCSF/Sustainable Technical and Analytics Resources for review of USAID oxygen investments, and reports investment in minimally invasive mitral valve prosthesis through Nininger Medical. The rest of the authors have no competing interests to report
Clinical Protocols
https://clinicaltrials.gov/study/NCT05538299
Funding Statement
This research received no specific grant from an NGO, not-for profit, private, commercial or federal funding source. It was funded internally under the Non-Communicable Diseases budget of Partners In Health-Rwanda otherwise known as Inshuti Mu Buzima.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Inshuti Mu Buzima Research Committee (IMBRC) and the Rwandan National Ethics Committee (RNEC) 110/RNEC/2022 gave ethical approval of this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.